What amounts has BPC-157 research actually used? The published animal figures, the human-tissue concentrations, and the honest answer on human dosing: none is published.
BPC-157 is studied in animal, cell, and tissue models of tendon, gut, blood vessel, nerve, and wound repair. A plain-language map of every research area.
A plain-language review of published BPC-157 wound research: a burn model, fistula repair in rats, and growth-factor comparisons. Animal and lab data only.
BPC-157 and KPV are studied for different things, and both appear in gut research. A plain-language look at what the published work covers and what it does not.
A plain-language comparison of BPC-157 and GHK-Cu: structure, size, the pathways each is studied through, the research areas each belongs to, and what neither has been tested for in people.
A plain-language look at what published BPC-157 tendon studies actually report, which of them used cells or animals, and what the research still does not show.
What the published record actually reports about BPC-157 safety: no Phase II or III human efficacy trial, small pilot infusion references, and open questions.
What published research says about BPC-157 and pain: a 2026 review of pain-signal mechanisms, the animal-model context, and the limits of the evidence.
What published research says about BPC-157 and muscle: a 2022 review across three muscle types, 2025 rat reattachment models, and what the animal evidence cannot answer.
What published research says about BPC-157 and ligaments: the 2010 rat MCL study, a 2026 mechanism review, and what the animal evidence does and does not show.










